logo
Select company
Select metric
$ 12MNet Cash Flow - Change in Cash & Cash Equivalents
VS
Market
67
Sector
77
Industry
81
History
83
$ 1.61Close
$ 1.51 - $ 9.22 52-Week Range
Ticker Information

Ticker

LUNG

Company Name

PULMONX CORP

Sector

Healthcare

Industry

Medical Devices

Exchange

NASDAQ

PULMONX CORP - Net Cash Flow - Change in Cash & Cash Equivalents Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LUNG - CF - Chg. Cash Historical data
DateNet Cash Flow - Change in Cash & Cash Equivalents
6/30/2025$ 12M
3/31/2025$ 4.42M
12/31/2024$ -12.62M
9/30/2024$ -31.61M
6/30/2024$ -38.33M
3/31/2024$ -40.24M
12/31/2023$ -18.18M
9/30/2023$ -17.45M
6/30/2023$ -20.13M
3/31/2023$ -18.76M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PULMONX CORP's latest trailing twelve months (TTM) CF - Chg. Cash stands at $ 217.03M.
  • Over the past 5 years, PULMONX CORP's average CF - Chg. Cash has been $ -1.26M.
  • The median CF - Chg. Cash for PULMONX CORP during this period was $ -19.45M
  • PULMONX CORP reached its highest CF - Chg. Cash over the past 5 years at $ 217.03M.
  • The lowest CF - Chg. Cash recorded by PULMONX CORP in the same timeframe $ -83.08M

PULMONX CORP's CF - Chg. Cash vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Chg. Cash Benchmarks
CompanyCF - Chg. Cash
TELA : TELA BIO INC $ 8.48MMYO : MYOMO INC $ 8.77MAPYX : APYX MEDICAL CORP $ -3.38MXTNT : XTANT MEDICAL HOLDINGS INC $ 1.56MBDSX : BIODESIX INC $ -21.49MSRTS : SENSUS HEALTHCARE INC $ 3.19MCTSO : CYTOSORBENTS CORP $ -3.22MSTRO : SUTRO BIOPHARMA INC $ -26.76MANIK : ANIKA THERAPEUTICS INC $ -9.65MMDAI : SPECTRAL AI INC $ 3.65M

Definition of Net Cash Flow - Change in Cash & Cash Equivalents

[Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]

LUNG - Net Cash Flow - Change in Cash & Cash Equivalents, Last 5 years

$ -83.08M

Minimum

Dec 31, 2021

$ 217.03M

Maximum

Dec 31, 2020

$ -1.26M

Average

$ -19.45M

Median

CF - Chg. Cash Benchmark Analysis

The chart above depicts the distribution of CF - Chg. Cash for companies in the Total Stock Market. The average CF - Chg. Cash of the companies is $ 1.17M with a standard deviation of $ 44.93M.
The following table provides additional summary stats:
CF - Chg. Cash in the Market:
filtered constituents3.34K
min$ -136.09M
max$ 137.58M
average$ 1.17M
median$ 115.89K
std$ 44.93M